KARS1 and lung carcinoma: For example, the KRS inhibitor BC-K-YH16899, binds to KRS and blocks the interaction between KRS and 67LR without affecting the catalytic activity of KRS, and has been validated to have an anti-metastatic effect in mouse model of lung cancer (Kim D. G. et al., 2014).